×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [30]
近代物理研究所 [8]
上海药物研究所 [7]
过程工程研究所 [2]
兰州理工大学 [1]
自动化研究所 [1]
更多...
内容类型
期刊论文 [49]
发表日期
2021 [49]
学科主题
基础医学 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共49条,第1-10条
帮助
限定条件
发表日期:2021
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
发表日期升序
发表日期降序
提交时间升序
提交时间降序
题名升序
题名降序
作者升序
作者降序
Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases
期刊论文
MOLECULAR BRAIN, 2021, 卷号: 14
作者:
Xu, Yanjun
;
Huang, Zhiyu
;
Yu, Xiaoqing
;
Chen, Kaiyan
;
Fan, Yun
收藏
  |  
浏览/下载:70/0
  |  
提交时间:2022/01/25
Brain metastases
Predictive biomarker
DNA methylation
Somatic mutation
Advanced non-small cell lung cancer (advanced NSCLC)
LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo
期刊论文
CANCER SCIENCE, 2021, 页码: 12
作者:
Liu, Yingqiang
;
Lai, Mengzhen
;
Li, Shan
;
Wang, Yanan
;
Feng, Fang
收藏
  |  
浏览/下载:58/0
  |  
提交时间:2022/01/18
C797S
epidermal growth factor receptor
fourth-generation EGFR TKI
non-small cell lung cancer
osimertinib resistance
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer
期刊论文
FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12
作者:
Peng, Jie
;
Zou, Dan
;
Han, Lijie
;
Yin, Zuomin
;
Hu, Xiao
收藏
  |  
浏览/下载:21/0
  |  
提交时间:2022/02/14
non-small cell lung cancer
support vector machine
major pathological response
liquid immune profiling
neoadjuvant treatment
A nomogram model based on peripheral blood lymphocyte subsets to assess the prognosis of non-small cell lung cancer patients treated with immune checkpoint inhibitors
期刊论文
TRANSLATIONAL LUNG CANCER RESEARCH, 2021
作者:
Xu, Xiaoling
;
Wang, Ding
;
Chen, Wei
;
Li, Na
;
Suwinski, Rafal
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2022/02/14
Immune checkpoint inhibitor (ICI)
non-small cell lung cancer (NSCLC)
peripheral blood lymphocyte subsets
Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells
期刊论文
Cancer Cell International, 2021, 卷号: 21, 期号: 1, 页码: 12
作者:
Zhao,Xueshan
;
Jin,Xiaodong
;
Zhang,Qiuning
;
Liu,Ruifeng
;
Luo,Hongtao
收藏
  |  
浏览/下载:157/0
  |  
提交时间:2021/12/13
LncRNA H19
MiR-130a-3p
WNK3
Non-small-cell lung cancer
Radiotherapy
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Wang, Liping
;
Pu, Xingxiang
;
Feng, Huijing
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2022/01/10
Non-small cell lung cancer
PD-L1
Immune checkpoint inhibitor
Immune-related adverse event
Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer
期刊论文
NATURE COMMUNICATIONS, 2021, 卷号: 12
作者:
Chen, Ming
;
Chen, Runzhe
;
Jin, Ying
;
Li, Jun
;
Hu, Xin
收藏
  |  
浏览/下载:41/0
  |  
提交时间:2022/01/10
Effect of autoinduction and food on the pharmacokinetics of furmonertinib and its active metabolite characterized by a population pharmacokinetic model
期刊论文
ACTA PHARMACOLOGICA SINICA, 2021, 页码: 10
作者:
Zou, Hui-xi
;
Zhang, Yu-feng
;
Zhong, Da-fang
;
Jiang, Yong
;
Liu, Fei
收藏
  |  
浏览/下载:17/0
  |  
提交时间:2022/01/04
furmonertinib
autoinduction
food effect
alkaline phosphatase
body weight
pharmacokinetics
modeling and simulation
NSCLC
Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma
期刊论文
FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 卷号: 8
作者:
Fan, Ying
;
Shan, Qianyun
;
Gong, Jiali
;
Qin, Jing
;
Lu, Hongyang
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2022/01/10
PPLELC
clinical characteristics
molecular characteristics
immunotherapy
PD-L1
TMB
Mechanism of Fuzheng Kang'ai Formula Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer
期刊论文
CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2021, 页码: 9
作者:
Tian Yun-ling
;
Fu Song-bo
;
Li Bo
;
Yuan Ling-yan
;
Bing Zhi-tong
收藏
  |  
浏览/下载:18/0
  |  
提交时间:2021/12/08
network pharmacology
prognosis
tumor microenvironment
Fuzheng Kang'ai Formula
Chinese medicine
lung adenocarcinoma
©版权所有 ©2017 CSpace - Powered by
CSpace